Skip to main content
Log in

Neuraxial clonidine is not associated with lower post-cesarean opioid consumption or pain scores in parturients on chronic buprenorphine therapy: a retrospective cohort study

  • Original Article
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

Purpose

Adequate post-cesarean delivery analgesia can be difficult to achieve for women diagnosed with opioid use disorder receiving buprenorphine. We sought to determine if neuraxial clonidine administration is associated with decreased opioid consumption and pain scores following cesarean delivery in women receiving chronic buprenorphine therapy.

Methods

This was a retrospective cohort study at a tertiary care teaching hospital of women undergoing cesarean delivery with or without neuraxial clonidine administration while receiving chronic buprenorphine. The primary outcome was opioid consumption (in morphine milligram equivalents) 0–6 h following cesarean delivery. Secondary outcomes included opioid consumption 0–24 h post-cesarean, median postoperative pain scores 0–24 h, and rates of intraoperative anesthetic supplementation. Multivariable analysis evaluating the adjusted effects of neuraxial clonidine on outcomes was conducted using linear regression, proportional odds model, and logistic regression separately.

Results

196 women met inclusion criteria, of which 145 (74%) received neuraxial clonidine while 51 (26%) did not. In univariate analysis, there was no significant difference in opioid consumption 0–6 h post-cesarean delivery between the clonidine (8 [IQR 0, 15]) and control (1 [IQR 0, 8]) groups (P = 0.14). After adjusting for potential confounders, there remained no significant association with neuraxial clonidine administration 0–6 h (Difference in means 2.77, 95% CI [− 0.89 to 6.44], P = 0.14) or 0–24 h (Difference in means 8.56, 95% CI [− 16.99 to 34.11], P = 0.51).

Conclusion

In parturients receiving chronic buprenorphine therapy at the time of cesarean delivery, neuraxial clonidine administration was not associated with decreased postoperative opioid consumption, median pain scores, or the need for intraoperative supplementation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hirai AH, Ko JY, Owens PL, Stocks C, Patrick SW. Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010–2017. JAMA. 2021;325(2):146–55.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death 1999–2017 on CDC WONDER Online Database. Atlanta: Centers for Disease Control and Prevention; 2020.

    Google Scholar 

  3. Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. MMWR Morb Mortal Wkly Rep. 2018;67(31):845–9.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Maeda A, Bateman BT, Clancy CR, Creanga AA, Leffert LR. Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology. 2014;121(6):1158–65.

    Article  PubMed  Google Scholar 

  5. Committee Opinion No. 711. Opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017;130(2):e81–94.

    Article  Google Scholar 

  6. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O’Grady KE, Selby P, Martin PR, Fischer G. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zedler BK, Mann AL, Kim MM, Amick HR, Joyce AR, Murrelle EL, Jones HE. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Addiction. 2016;111(12):2115–28.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003;70(2 Suppl):S13-27.

    Article  CAS  PubMed  Google Scholar 

  9. Meyer M, Paranya G, Norris AK, Howard D. Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy. Eur J Pain. 2010;14(9):939–43.

    Article  CAS  PubMed  Google Scholar 

  10. Tith S, Bining G, Bollag L. Management of eight labor and delivery patients dependent on buprenorphine (SubutexTM): a retrospective chart review. F1000Res. 2018;7:7.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Eisenach JC, Pan PH, Smiley R, Lavand’homme P, Landau R, Houle TT. Severity of acute pain after childbirth, but not type of delivery, predicts persistent pain and postpartum depression. Pain. 2008;140(1):87–94.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Moriyama K, Ohashi Y, Motoyasu A, Ando T, Moriyama K, Yorozu T. Intrathecal administration of morphine decreases persistent pain after cesarean section: a prospective observational study. PLoS ONE. 2016;11(5): e0155115.

    Article  Google Scholar 

  13. Babazade R, Vadhera RB, Krishnamurthy P, Varma A, Doulatram G, Said GR, Turan A. Acute postcesarean pain is associated with in-hospital exclusive breastfeeding, length of stay and post-partum depression. J Clin Anesth. 2020;62: 109697.

    Article  PubMed  Google Scholar 

  14. Paech MJ, Pavy TJG, Orlikowski CEP, Yeo ST, Banks SL, Evans SF, Henderson J. Postcesarean analgesia with spinal morphine, clonidine, or their combination. Anesth Analg. 2004;98(5):1460–6.

    Article  CAS  PubMed  Google Scholar 

  15. Neves JF, Monteiro GA, Almeida JR, Sant’anna RS, Saldanha RM, Moraes JMS, Nogueira ES, Coutinho FL, Neves MMP, Araujo FP, Nobrega PB. Postoperative analgesia for cesarean section: does the addition of clonidine to subarachnoid morphine improve the quality of the analgesia? Rev Bras Anestesiol. 2006;56(4):370–6.

    Article  PubMed  Google Scholar 

  16. Crespo S, Dangelser G, Haller G. Intrathecal clonidine as an adjuvant for neuraxial anaesthesia during caesarean delivery: a systematic review and meta-analysis of randomised trials. Int J Obstet Anesth. 2017;32:64–76.

    Article  CAS  PubMed  Google Scholar 

  17. Filos KS, Goudas LC, Patroni O, Polyzou V. Intrathecal clonidine as a sole analgesic for pain relief after cesarean section. Anesthesiology. 1992;77(2):267–74.

    Article  CAS  PubMed  Google Scholar 

  18. Allen TK, Mishriky BM, Klinger RY, Habib AS. The impact of neuraxial clonidine on postoperative analgesia and perioperative adverse effects in women having elective caesarean section—a systematic review and meta-analysis. Br J Anaesth. 2018;120(2):228–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Paech MJ, Pavy TJG, Orlikowski CEP, Evans SF. Patient-controlled epidural analgesia in labor: the addition of clonidine to bupivacaine-fentanyl. Reg Anesth Pain Med. 2000;25(1):34–40.

    CAS  PubMed  Google Scholar 

  20. Landau R, Schiffer E, Morales M, Savoldelli G, Kern C. The dose-sparing effect of clonidine added to ropivacaine for labor epidural analgesia. Anesth Analg. 2002;95(3):728–34.

    Article  CAS  PubMed  Google Scholar 

  21. Hoyt MR, Shah U, Cooley J, Temple M. Use of epidural clonidine for the management of analgesia in the opioid addicted parturient on buprenorphine maintenance therapy: an observational study. Int J Obstet Anesth. 2018;34:67–72.

    Article  CAS  PubMed  Google Scholar 

  22. Cook MI, Kushelev M, Coffman JH, Coffman JC. Analgesic outcomes in opioid use disorder patients receiving spinal anesthesia with or without intrathecal clonidine for cesarean delivery: a retrospective investigation. J Pain Res. 2022;15:1191–201.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Eisenach JC, Hood DD, Curry R. Intrathecal, but not intravenous, clonidine reduces experimental thermal or capsaicin-induced pain and hyperalgesia in normal volunteers. Anesth Analg. 1998;87:591–6.

    Article  CAS  PubMed  Google Scholar 

  24. Hassenbusch SJ, Gunes S, Wachsman S, Willis KD. Intrathecal clonidine in the treatment of intractable pain: a phase I/II study. Pain Med. 2002;3:85–91.

    Article  PubMed  Google Scholar 

  25. Siddall PJ, Molloy AR, Walker S, Mather LE, Rutkowski SB, Cousins MJ. The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury. Anesth Analg. 2000;91:1493–8.

    Article  CAS  PubMed  Google Scholar 

  26. Glynn C, Dawson D, Sanders R. A double-blind comparison between epidural morphine and epidural clonidine in patients with chronic non-cancer pain. Pain. 1988;34:123–8.

    Article  PubMed  Google Scholar 

  27. Rack RL, Eisenach JC, Jackson K, Young LD, Southern J. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology. 1993;79:1163–9.

    Article  Google Scholar 

  28. Eisenach JC, DuPen S, Dubois M, Miguel R, Allin D. Epidural clonidine analgesia for intractable cancer pain. The epidural clonidine study group. Pain. 1995;61:391–9.

    Article  PubMed  Google Scholar 

  29. Greenwald MK, Comer SD, Fiellin DA. Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy. Drug Alcohol Depend. 2014;144:1–11.

    Article  CAS  PubMed  Google Scholar 

  30. Young JL, Lockhart EM, Baysinger CL. Anesthetic and obstetric management of the opioid dependent parturient. Int Anesthesiol Clin. 2014;52(2):67–85.

    Article  PubMed  Google Scholar 

  31. Pan PH. Post cesarean delivery pain management: multimodal approach. Int J Obstet Anesth. 2006;15(3):185–8.

    Article  PubMed  Google Scholar 

  32. Cavens L, Roofthooft E. Neuraxial labor analgesia: is there a place for neuraxial adjuvants beyond opioids. Best Pract Res Clin Anaesthesiol. 2022;36(1):31–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael G. Taylor.

Ethics declarations

Conflict of Interest

The authors certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 25 KB)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taylor, M.G., Bauchat, J.R., Sorabella, L.L. et al. Neuraxial clonidine is not associated with lower post-cesarean opioid consumption or pain scores in parturients on chronic buprenorphine therapy: a retrospective cohort study. J Anesth 38, 339–346 (2024). https://doi.org/10.1007/s00540-024-03314-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-024-03314-8

Keywords

Navigation